Immunotherapy in Lymphoma
Recruiting now
Conditions studied: Relapsed/refractory High Grade B Cell Lymphoma, High Grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma Relapsed, Primary Mediastinal Large B-Cell Lymphoma, Burkitt Lymphoma
In brief
The goal of this observational study is to compare the efficacy of advanced immunochemotherapy and classical immunochemotherapy in relapsed/refractory high grade B cell lymophoma patients. The main question it aims to answer is: Does advanced immunochemotherapy, including CAR-T therapy, bispecific antibody, and antibody-drug conjugate offer superior survival outcomes than when treated with classical immunochemotherapy, such as proteasome inhibitors, immune modulatory drugs, and monoclonal antibodies? Researchers will compare patients receiving advanced immunochemotherapy with those receiving classical immunochemotherapy to determine if advanced therapies result in better survival outcomes. Laboratory findings and electronic medical records (EMR) from participants will be used to assess survival outcomes and treatment-related safety profiles.
Key facts
- Study ID
- NCT06796517
- Run by
- Sung-Soo Park
- People needed
- 72
- Starts
- 2024-06-26
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-01-28
Who can join
Age: 19 and older, up to 74. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 19 to 74 years.
- Diagnosed with any of the following after January 2015: diffuse large B cell lymphoma, primary mediastinal large B cell lymphoma, high grade B cell lymphoma, or Burkitt lymphoma
- Patients who have received immunochemotherapy as treatment for relapsed/refractory lymphoma
You may not qualify if…
- Patients who have progressed to acute leukemia
- Patients who developed solid tumor during treatment
- Patients with active infectious status (acute pneumonia, viral infection, active hepatitis B state, or active pulmonary tuberculosis etc.)
Where it is running
- Seoul St. Mary Hospital — Seoul, South Korea (enrolling)
- Yeoido St. Mary Hospital — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.